Skip to main content
Clinical Trials/CTRI/2024/05/066773
CTRI/2024/05/066773
Not yet recruiting
Phase 4

A Randomised double arm parallel clinical study to compare effectiveness of Individualised homoeopathic medicine versus Histaminum in the management of allergic rhinitis - Nil

DR Subhi Jain0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Sponsor
DR Subhi Jain
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
DR Subhi Jain

Eligibility Criteria

Inclusion Criteria

  • Patients having clinical signs and symptoms of Allergic Rhinitis as per ICD 10 classification J30\.411
  • Pre diagnosed cases of Allergic Rhinitis.
  • Patients who have not taken any treatment since last 1 week for Allergic Rhinitis .
  • Patients willing to take homoeopathic treatment
  • Patients giving informed consent.

Exclusion Criteria

  • Patients with serious complications and other uncontrolled or life\-threatening systemic illness.
  • Case of Nasal Polyp ,Deviated Nasal Septum ,Sinusitis, Allergic Bronchitis , Asthma or other Respiratory illness resembling allergic rhinitis
  • Diagnosed cases of Psychiatric illness.
  • Pregnant women and Lactating mothers.
  • Substance abuse/ Dependence.
  • Patients who are not willing to be a part of this study.
  • Self\-reported Immunocompromised state

Outcomes

Primary Outcomes

Not specified

Similar Trials